Publications by authors named "Vasiliki Chasapi"

Claim this Profile
S
Sjögren disease and cutaneous sarcoidosis: an association to consider or a co-existence?
Stella Kaliampou, Maria Gerochristou, Efthymia Soura, Theodora Douvali, Vasiliki Chasapi

Clin Rheumatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life, psychosocial difficulties and bullying in paediatric patients with alopecia areata: a European cross-sectional study.
Agathe Franz, Andria Constantinou, Kathrin Hillmann, Vasiliki Chasapi, Sergio Vañó Galván

Br J Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effectiveness, safety and prognostic factors of response to treatment with bimekizumab in psoriasis patients: results from a real-world multicentre study.
Alexander Katoulis, Evangelia Papadavid, Ioannis-Alexios Koumprentziotis, Natalia Rompoti, Irene Stefanaki, Vasiliki Chasapi

Clin Exp Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regression of Eruptive Syringomas Following Immune Modulation in an Elderly Male With Psoriasis.
Andriani Tsiakou, Melpomeni Theofili, Alexios Zarras, Emmanouil Karampinis, Vasiliki Chasapi

Int J Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Outcomes of Guselkumab and Risankizumab for the Management of Moderate-to-Severe Psoriasis in the Elderly: Results from a Real-World Retrospective Study.
Ioannis-Alexios Koumprentziotis, Irene Stefanaki, Eleni Routsi, Charitomeni Vavouli, Pantelis Panagakis, Vasiliki Chasapi

J Clin Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 30-Year Epidemiological Study of Opportunistic Fungal Infections in People Living with HIV in Greece: Associations with Demographic Characteristics and Immune Status.
Theodora Douvali, Vasilios Paparizos, Varvara Vasalou, Stamatios Gregoriou, Vasiliki Chasapi

J Clin Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bimekizumab Treatment for Scalp Psoriasis: A 52-Week, Real-World, Retrospective Study.
Irene Stefanaki, Ioannis-Alexios Koumprentziotis, Natalia Rompoti, Pantelis Panagakis, Charitomeni Vavouli, Vasiliki Chasapi

Int J Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching from intravenous to subcutaneous infliximab in patients with immune mediated diseases in clinical remission.
Nikos Viazis, Anastasios Karamanakos, Konstantinos Mousourakis, Angeliki Christidou, Fotios Fousekis, Vasiliki Chasapi

Front Med (Lausanne)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epistasis of ERAP1 With 4 Major Histocompatibility Complex Class I Alleles in Frontal Fibrosing Alopecia: A Genome-Wide Association Study Meta-Analysis.
Tuntas Rayinda, Nick Dand, Sheila M McSweeney, Evangelos Christou, Chuin Ying Ung, Vasiliki Chasapi

JAMA Dermatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness, drug survival and safety of risankizumab over a period of 2 years in 158 patients with moderate-to-severe plaque psoriasis.
Natalia Rompoti, Irene Stefanaki, Pantelis Panagakis, Marina Papoutsaki, Maria Politou, Vasiliki Chasapi

J Eur Acad Dermatol Venereol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case of Tungiasis in a Greek Patient: A Tropical Souvenir.
Theodora Douvali, Theodora Zafeiropoulou, Georgios Sarris, Anna Danai Panopoulou, Panorea Georgia Antonatou, Vasiliki Chasapi

Cureus· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness and drug survival of guselkumab over a period of 3 years in moderate-to-severe plaque psoriasis, including difficult-to-treat areas.
Natalia Rompoti, Theognosia Vergou, Irene Stefanaki, Charitomeni Vavouli, Ioannis-Alexios Koumprentziotis, Vasiliki Chasapi

Int J Dermatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risankizumab in obese patients with moderate-to-severe plaque psoriasis: a 104-week, real-world, retrospective study.
Natalia Rompoti, Ioannis-Alexios Koumprentziotis, Irene Stefanaki, Charitomeni Vavouli, Marina Papoutsaki, Vasiliki Chasapi

Arch Dermatol Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unveiling the Impact of Moderate and Severe Atopic Dermatitis: Insights on Burden, Clinical Characteristics, and Healthcare Resource Utilization in Adult Greek Patients from the APOLO Cross-Sectional Study.
Alexander J Stratigos, Vasiliki Chasapi, Alexander Katoulis, Efstratios Vakirlis, Fotios Psarros

J Clin Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world data on the effectiveness of brodalumab in patients with moderate-to severe plaque psoriasis in the Greek clinical setting (the BrIDGE study).
Dimitrios Rigopoulos, Eleftheria Tampouratzi, Charalampos Angelakopoulos, Zoe Apalla, Ioannis Barkis, Vasiliki Chasapi

J Eur Acad Dermatol Venereol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bimekizumab in psoriasis: a monocentric study evaluating short- and mid-term effectiveness and safety profile in a real-world setting.
Natalia Rompoti, Irene Stefanaki, Pantelis Panagakis, Charitomeni Vavouli, Maria Politou, Vasiliki Chasapi

Arch Dermatol Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factitious Disorder as a Skin Ulcer: A Case Report.
Konstantinos Kontoangelos, Fiori Kousta, Irene Potouridou, Vasiliki Chasapi, Dimitris Dikeos

Cureus· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shared Genetic Risk Variants in Both Male and Female Frontal Fibrosing Alopecia.
Tuntas Rayinda, Sheila M McSweeney, David Fenton, Catherine M Stefanato, Matthew Harries, Vasiliki Chasapi

J Invest Dermatol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective study of small-diameter invasive melanomas: Metastasis at diagnosis and 9-year follow-up.
Clio Dessinioti, Michaella Plaka, Katerina Kypreou, Aravella Stergiopoulou, Maria Kostaki, Vasiliki Chasapi

J Am Acad Dermatol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous melanoma metastases: Clinical and dermoscopic findings.
Maria Kostaki, Michaela Plaka, Margarita Moustaki, Aggeliki Befon, Grigoris Champsas, Vasiliki Chasapi

J Eur Acad Dermatol Venereol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real world experience of brodalumab treatment in patients with moderate-to-severe plaque psoriasis in the Greek population: Results from an interim analysis of the BrIDGE study.
Dimitrios Rigopoulos, Charalampos Angelakopoulos, Zoi Apalla, Sophia Georgiou, Florentina Delli, Vasiliki Chasapi

Dermatol Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical evidence on the use of brodalumab for the treatment of psoriasis in Greece: Experience from clinical practice of four tertiary hospitals.
Eleftheria Tampouratzi, Markos Papakonstantis, John Katsantonis, Theodoros Sidiropoulos, Florentina Delli, Vasiliki Chasapi

Dermatol Ther· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sub-population analysis of patients with plaque psoriasis treated with calcipotriol/betamethasone aerosol foam; effectiveness and patient satisfaction, according to baseline disease severity and prior psoriasis treatment experience, in a Greek population.
Dimitrios Rigopoulos, Elisavet Lazaridou, Evangelia Papadavid, Sophia Georgiou, Vasiliki Chasapi

Dermatol Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harlequin syndrome in a young girl: An opportunity to rethink the terminology.
Theodora Douvali, Vasiliki Papageorgiou, Maria Gerochristou, Maria Gerodimou, Eleftheria Tampouratzi, Vasiliki Chasapi

Pediatr Dermatol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Total 25-Hydroxyvitamin D Levels in Patients With Cutaneous Malignant Melanoma: A Case-Control Study in a Low-Risk Southern European Population.
Angeliki Befon, Alexander C Katoulis, Sofia Georgala, Andreas Katsampas, Vasiliki Chardalia, Vasiliki Chasapi

Dermatol Pract Concept· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis